Evidence map›Paper›PMID 32332853›Full record

ArticleScientific reports2020

A 96-well culture platform enables longitudinal analyses of engineered human skeletal muscle microtissue strength.

Mohammad E Afshar, Haben Y Abraha, Mohsen A Bakooshli, Sadegh Davoudi, Nimalan Thavandiran, Kayee Tung, Henry Ahn, Howard J Ginsberg, Peter W Zandstra, Penney M Gilbert

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Mohammad E Afshar *Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Canada.
Haben Y Abraha *Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Canada.
Mohsen A Bakooshli *Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Canada.
Sadegh DavoudiInstitute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Canada.
Nimalan ThavandiranInstitute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Canada.
Kayee TungLi Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada.
Henry AhnLi Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada.
Howard J GinsbergInstitute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Canada.
Peter W ZandstraInstitute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Canada.
Penney M GilbertInstitute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Canada. penney.gilbert@utoronto.ca.
University of Toronto · CAOccupational Cancer Research Centre · CASt. Michael's Hospital · CACanada's Michael Smith Genome Sciences Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three-dimensional (3D) in vitro models of human skeletal muscle mimic aspects of native tissue structure and function, thereby providing a promising system for disease modeling, drug discovery or pre-clinical validation, and toxicity testing. Widespread adoption of this research approach is hindered by the lack of easy-to-use platforms that are simple to fabricate and that yield arrays of human skeletal muscle micro-tissues (hMMTs) in culture with reproducible physiological responses that can be assayed non-invasively. Here, we describe a design and methods to generate a reusable mold to fabricate a 96-well platform, referred to as MyoTACTIC, that enables bulk production of 3D hMMTs. All 96-wells and all well features are cast in a single step from the reusable mold. Non-invasive calcium transient and contractile force measurements are performed on hMMTs directly in MyoTACTIC, and unbiased force analysis occurs by a custom automated algorithm, allowing for longitudinal studies of function. Characterizations of MyoTACTIC and resulting hMMTs confirms the capability of the device to support formation of hMMTs that recapitulate biological responses. We show that hMMT contractile force mirrors expected responses to compounds shown by others to decrease (dexamethasone, cerivastatin) or increase (IGF-1) skeletal muscle strength. Since MyoTACTIC supports hMMT long-term culture, we evaluated direct influences of pancreatic cancer chemotherapeutics agents on contraction competent human skeletal muscle myotubes. A single application of a clinically relevant dose of Irinotecan decreased hMMT contractile force generation, while clear effects on myotube atrophy were observed histologically only at a higher dose. This suggests an off-target effect that may contribute to cancer associated muscle wasting, and highlights the value of the MyoTACTIC platform to non-invasively predict modulators of human skeletal muscle function.

Indexed as

Antineoplastic AgentsBiomechanical PhenomenaCalciumHumansMuscle, SkeletalTissue EngineeringAntineoplastic AgentsCalcium

Identifiers

PMID32332853
PMCPMC7181829
OpenAlexW3019798172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.